Meloprol (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the synthesis of prostaglandins—key mediators of inflammation, pain, and fever—thereby providing anti‑inflammatory and analgesic effects while sparing COX‑1 activity.

The appropriate dose of Meloprol is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual response. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of meloxicam in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Meloprol, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Meloprol (meloxicam) is a COX‑2‑selective NSAID, which generally offers a lower risk of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, it still carries cardiovascular and renal risks that must be weighed against its benefits.

Meloprol should be stored at room temperature, below 25 °C, in its original container, protected from moisture, heat, and direct sunlight. Do not store in a bathroom or near a kitchen sink where humidity is high.

Meloprol is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help reduce gastrointestinal discomfort.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), and renal impairment. Patients should seek immediate medical attention if they experience symptoms like severe abdominal pain, chest pain, or unexplained bruising.

Meloprol should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration, severe heart failure, or significant renal or hepatic impairment unless specifically directed by a physician.